Browse Category

Stock Market News 18 December 2025

Ford Stock (NYSE: F) Today: EV Strategy Reset, LG Battery Deal Cancellation, and What Analysts Forecast for 2026

Ford Stock (NYSE: F) Today: EV Strategy Reset, LG Battery Deal Cancellation, and What Analysts Forecast for 2026

Ford Motor Company stock is in the spotlight on Thursday, Dec. 18, 2025, as investors digest a rapid-fire sequence of headlines: the automaker’s sweeping EV strategy overhaul, a $19.5 billion EV-related charge, and fresh confirmation that Ford has terminated a major EV battery-supply agreement with South Korea’s LG Energy Solution. Reuters As of 12:38 UTC (7:38 a.m. ET), Ford stock…
Nvidia (NVDA) Stock Today: AI Funding Jitters, Blackwell Demand Signals, and Fresh Analyst Forecasts (Dec. 18, 2025)

Nvidia (NVDA) Stock Today: AI Funding Jitters, Blackwell Demand Signals, and Fresh Analyst Forecasts (Dec. 18, 2025)

NVIDIA Corporation (NASDAQ: NVDA) is ending 2025 the way it lived it: at the center of a global tug‑of‑war between “AI spend is unstoppable” and “AI spend is expensive.” On December 18, 2025, that tension is showing up in both the tape and the headlines—ranging from shifting data‑center funding narratives and new Blackwell buildouts, to U.S.–China export policy twists, competitive…
Opendoor Stock (OPEN) Update Dec. 18, 2025: New President, Warrant Dividend Fallout, and a Wide-Swing Analyst Outlook

Opendoor Stock (OPEN) Update Dec. 18, 2025: New President, Warrant Dividend Fallout, and a Wide-Swing Analyst Outlook

Opendoor Technologies Inc. (NASDAQ: OPEN) stock is back in the spotlight on Thursday, December 18, 2025—caught between a leadership reshuffle, a complex warrant-dividend structure that still echoes through trading, and a forecast landscape where analyst price targets don’t just disagree… they practically live in different universes. After closing at $6.12 on December 17 (down 9.06% on the day), OPEN was…
Comcast Stock (CMCSA) Today: Versant Spinoff Details, Activist Buzz, and Fresh 2026 Forecasts (Dec. 18, 2025)

Comcast Stock (CMCSA) Today: Versant Spinoff Details, Activist Buzz, and Fresh 2026 Forecasts (Dec. 18, 2025)

Dec. 18, 2025 — Comcast Corporation’s stock (NASDAQ: CMCSA) is back in the spotlight this week, not because the cable giant suddenly reinvented the internet, but because a rare mix of corporate restructuring, activist-investor chatter, and near-term earnings visibility has collided at the same time. As of early trading on December 18, 2025, CMCSA was around $30.32. That price point…
Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts

Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts

Pfizer Inc. (NYSE: PFE) stock is trying to steady itself in late December after a volatile stretch driven by one big theme: the post-COVID hangover is still real, and 2026 is shaping up as another “rebuild” year—even as Pfizer spends aggressively to reload its pipeline. As of Thursday, Dec. 18, 2025, Pfizer shares traded around $25.04, down about 1.8% from…
Warner Bros. Discovery Stock (WBD) News Today: Standard General CNN Talks, Netflix Deal Terms, Paramount Bid Deadline, and Wall Street Forecasts (Dec. 18, 2025)

Warner Bros. Discovery Stock (WBD) News Today: Standard General CNN Talks, Netflix Deal Terms, Paramount Bid Deadline, and Wall Street Forecasts (Dec. 18, 2025)

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is trading like a company caught in a live-action script rewrite: two giant suitors, a looming tender-offer deadline, and now fresh reporting that could reshape the value of its cable-network “leftovers.” As of the latest available quote heading into Thursday, Dec. 18, 2025, WBD shares were around $28.21. Warner Bros. Discovery IRThat price matters…
Recursion Pharmaceuticals (RXRX) Stock News & Forecast (Dec. 18, 2025): JPMorgan Upgrade, REC-4881 Trial Momentum, and What Analysts See Next

Recursion Pharmaceuticals (RXRX) Stock News & Forecast (Dec. 18, 2025): JPMorgan Upgrade, REC-4881 Trial Momentum, and What Analysts See Next

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is back in the market’s spotlight on December 18, 2025, after a sharp move higher driven by fresh Wall Street optimism and a growing pile of real-world “proof points” for the company’s AI-driven drug discovery thesis. The setup is classic biotech: a clinical readout starts the spark, an analyst upgrade adds oxygen, and the stock…
Broadcom (AVGO) Stock Slides on AI Funding Fears Despite Upbeat Guidance: News, Forecasts and Analyst Price Targets on Dec. 18, 2025

Broadcom (AVGO) Stock Slides on AI Funding Fears Despite Upbeat Guidance: News, Forecasts and Analyst Price Targets on Dec. 18, 2025

Broadcom Inc. (NASDAQ: AVGO) is back in the market’s spotlight on Thursday, December 18, 2025—caught in the crosswinds of two powerful narratives that don’t always play nicely together: surging AI infrastructure demand and fresh anxiety about who will finance the next wave of mega–data centers. As of 12:07 UTC on Dec. 18, Broadcom shares were $326.02, down $15.25 (-4.47%). The…
Tesla Stock Today (TSLA): Shares Slide After California “Autopilot” Ruling as Robotaxi Bets Collide With AI Selloff (Dec. 18, 2025)

Tesla Stock Today (TSLA): Shares Slide After California “Autopilot” Ruling as Robotaxi Bets Collide With AI Selloff (Dec. 18, 2025)

Tesla, Inc. stock is taking a breather after sprinting to fresh highs earlier this week—reminding investors that TSLA doesn’t just trade on car deliveries anymore. It trades on narratives. And right now, two big ones are colliding: regulatory scrutiny over “Autopilot” marketing in California and the market’s growing anxiety about richly valued AI-linked stocks. Reuters As of Thursday morning, Tesla…
Luminar Technologies (LAZR) Stock Update on Dec. 18, 2025: Chapter 11 Bankruptcy, $110M Sale Deal, Nasdaq Delisting Risk, and What Investors Are Watching

Luminar Technologies (LAZR) Stock Update on Dec. 18, 2025: Chapter 11 Bankruptcy, $110M Sale Deal, Nasdaq Delisting Risk, and What Investors Are Watching

Luminar Technologies, Inc. (NASDAQ: LAZR) has entered a new—and brutally high-stakes—phase of its story: a court-supervised restructuring built around selling major pieces of the company. As of Dec. 18, 2025, LAZR shares are trading around $0.23, reflecting extreme volatility after the company filed for Chapter 11 bankruptcy protection and outlined plans to sell both its LiDAR business and the equity…
Nike Stock (NKE) Today: Q2 FY2026 Earnings Preview, Analyst Targets, and Turnaround Risks to Watch on Dec. 18, 2025

Nike Stock (NKE) Today: Q2 FY2026 Earnings Preview, Analyst Targets, and Turnaround Risks to Watch on Dec. 18, 2025

Dec. 18, 2025 — NIKE, Inc. (NYSE: NKE) is in the spotlight today as investors brace for the company’s fiscal second-quarter 2026 earnings report due after the market close. Shares have been trading in the mid-$60s range, with Nike’s investor site showing an intraday range of $65.56–$67.81 and a 52-week range of $52.28–$82.44. Nike Investors The timing matters: for the…
PayPal Stock (PYPL) Slides After Morgan Stanley Downgrade: PayPal Bank Charter Bid, “Agentic Commerce” Debate, and 2026 Analyst Forecasts (Dec. 18, 2025)

PayPal Stock (PYPL) Slides After Morgan Stanley Downgrade: PayPal Bank Charter Bid, “Agentic Commerce” Debate, and 2026 Analyst Forecasts (Dec. 18, 2025)

PayPal Holdings, Inc. (NASDAQ: PYPL) is back in the market’s spotlight on Thursday, December 18, 2025—and not in the comfy, “everyone agrees what this company is” way. Shares traded around $60 today, down roughly 2% on the session, leaving PayPal near the lower end of its 52‑week range as investors weigh a fresh analyst downgrade against a string of strategic…

Stock Market Today

  • Old Republic International (ORI) Shares Drop 18.6% but Overshadowed by Potential Undervaluation
    January 24, 2026, 4:38 PM EST. Old Republic International (ORI) shares have fallen 18.6% over the past month, amid a year-to-date decline of 12.3%. Despite this, the insurer posted a 14.1% return over the last year and an 80.5% return over three years. Valuation models suggest the stock may be undervalued by approximately 43%, with an intrinsic value estimated at $66.97 per share versus the current price of $37.94. The company's stable return on equity of 12.67% and its broad insurance exposure bolster its long-term prospects. Investors should weigh recent price drops against underlying fundamentals, as metrics point to potential value after recent declines.
Go toTop